The incidence of retinopathy of prematurity (ROP) continues to rise due to the improved
survival of very low birth weight infants in developed countries. This epidemic is also fueled …

Topic To compare bevacizumab, ranibizumab, aflibercept, and laser treatment as primary
therapies for retinopathy of prematurity (ROP) in terms of retreatment rate. Clinical relevance …

Background To evaluate the prevalence, risk factors and treatment of retinopathy of
prematurity (ROP) in Turkey and to establish screening criteria for this condition. Methods A …

Importance A retinopathy of prematurity (ROP) diagnosis currently relies on indirect
ophthalmoscopy assessed by experienced ophthalmologists. A deep learning algorithm …

Background/aims During the last decade, improved neonatal care has resulted in increased
survival of the most immature infants and improved health of more mature infants. We …

Several epidemics of blindness due to retinopathy of prematurity (ROP) have been
described, with the most recent (the third) occurring in middle income countries in Latin …

The aim of this study is to investigate the nationwide incidence and treatment pattern of
retinopathy of prematurity (ROP) in South Korea. Using the population-based National …

Introduction Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the
premature retina with the potential to progress to extraretinal neovascularisation. This review …

Simple Summary Visual loss and blindness caused by retinal disease has a significant
negative effect on the quality of life of many adults and children, and as a result has become …

Background: Oral propranolol reduces retinopathy of prematurity (ROP) progression,
although not safely. Propranolol 0.1% eye micro-drops administered to newborns with stage …